The Body's Lipodystrophy Forum Welcomes New Expert
Dr. Graeme Moyle, a British HIV physician and an expert on issues related to the body fat changes caused by HIV and HAART, is our newest member of The Body's "Ask the Experts" forum on lipodystrophy and wasting. Stop in now and ask him your questions!
Share Your Artistic Vision, Win Prizes and Raise CMV Awareness
Visual AIDS has begun the 2003 "Share Your Vision" art contest, a unique competition which aims to raise awareness of CMV retinitis. Prizes will be awarded to the winners, and matching gifts will be donated to HIV/AIDS charities of the winners' choice! Click on the link below to find out more; entries are due on June 16.
HIV Treatment in 2003: Not New, Just Different
Changes in antiretroviral therapy from 2002 to 2003 are more evolutionary than revolutionary, says Dr. Jonathan Uy, an AIDS researcher and professor of medicine at the University of Chicago. There are some new drugs -- and new forms of old drugs -- but mostly we've just learned how to better use the drugs that are currently out there.
How Do Some At-Risk Men Stay HIV-Free? It's in Their Blood
Why can some HIV-negative men repeatedly have unprotected sex with their HIV-positive female partners yet not get infected? According to researchers, these men carry relatively high levels of antibodies that specifically fight HIV infection. For more details on this fascinating study, click here.
Film Brings to Life True Meaning of "Global AIDS"
A Closer Walk, the first feature-length film ever to document the impact of HIV/AIDS throughout the world, is now being shown at select screenings throughout the country. The film's next viewing is April 6 in Princeton, N.J.
The Oscar-nominated director of A Closer Walk, Robert Bilheimer, wrote a series of journal entries while he was traveling the world to film his movie. Each journal provides a moving, often wrenching view of what life is like for people with HIV in various parts of the developing world. Browse through The Body's full collection of these journals.
How to Counter Bush's Abstinence Stance
Jim Pickett, as always, is passionate about being an activist. This time he takes on the Bush administration's devotion to abstinence-only prevention and sex education and tells us how to make a difference if we disagree with it.
Why New Vitamin Rules Matter to You
What's so important about the U.S. Food and Drug Administration's recent decision to impose stricter rules on the labeling of dietary supplements? This FDA factsheet has the answers.
New Drugs May Keep HIV From Coming Together
Researchers have identified new compounds that can interfere with the assembly of HIV in lab tests. This new discovery lays the groundwork for the development of a potentially new class of drugs: "assembly inhibitors."
Caution, Awareness Urged on Staph Infection Outbreak
The recent outbreaks of drug-resistant staph infections (a.k.a. MRSA) in gay populations in San Francisco, Los Angeles and other cities shouldn't be regarded as some kind of superbug or as a specifically gay issue, says Dr. Kenneth Haller of the Gay and Lesbian Medical Association. Many other communities are at risk too, he notes, but the infection itself isn't terribly dangerous -- unless the wrong antibiotic is prescribed.
Oral Sex and HIV: Relatively Low Transmission Risk
There's nothing terribly new in this report, but recent laboratory studies of mouth tissue have found that unprotected oral sex does have the potential to transmit HIV. However, one top HIV researcher noted that it's still far less risky than other routes of transmission.
Helping Drug Users: Better Than Just Arresting Them
As we all know, simplistic solutions to the United States' drug problems won't do the trick. "Answering 'Just Say No' to a complicated question like why people use drugs in the first place won't work," says Don McVinney, a harm reduction trainer. In this interview, he discusses how harm reduction tries to make using drugs safer for people who won't -- or can't -- quit.
Important HIV Research Presented in Glasgow 2002
The HIV conference in Glasgow last November -- also known as the 6th International Congress on Drug Therapy in HIV Infection -- included some pretty significant research on drug combinations, HIV treatment strategies and lipodystrophy. Click here to read a conference review from IAPAC.
For more details on specific studies presented at Glasgow, read through The Body's extensive coverage!
HIV Conferences Outside the Mainstream
There is a variety of different HIV-related conferences during the course of a year. The Body covers the major ones, but what about some of the lesser-known conferences? David Barr reviews three of them, which took place in Yokohama, Vancouver and Geneva.
Guide to Prisoners' Mental Health Care
The HIV Prison Education Project has put together this guide to the mental health care of prisoners in the U.S. with HIV or chronic hepatitis.
A Selection of the Top HIV/AIDS Stories From Across the Internet:
HIV/AIDS vs. the People: The Case of Life and Death
The spread of HIV in Nigeria has gone from alarming (epidemic) to ominous (pandemic): an estimated 1.4 million people died from HIV/AIDS in 2002 alone.
Editorial from This Day, Lagos (April 2, 2003)
Atazanavir Resistance: Use as Second- or Third-Line PI Should Not Be Ruled Out
Evidence that this drug in development may be more than a first-line treatment.
Article from aidsmap.com (April 1, 2003)
Southeast Asia: 700,000 New HIV Cases in 2002
Experts warn those numbers will likely grow unless more is done to fight HIV stigma in the region.
Article from Daily Times, Pakistan (April 1, 2003)
Gates Foundation Makes $60 Million Grant to Accelerate HIV/AIDS Microbicide Research
The record-setting grant will allow for a "venture capital" approach to microbicide development.
Press release from the International Partnership for Microbicides
(March 31, 2003)
Five Brand-Name Drug Manufacturers Overcharged ADAPs, Other "Safety Net" Providers $6.1 Million for Drugs, U.S. Department of Health and Human Services Office of the Inspector General Says
The companies were not named, but five is more than half the number of companies producing currently approved HIV drugs.
Article from kaisernetwork.org (March 27, 2003)
Microbicides, Barriers, and Mucosal Immunity: The First and Second Lines of Defense Against HIV Infection in Women
A slide show and audio presentation.
Multimedia presentation (in RealAudio format) from HIV InSite (January 27, 2003)
For more about microbicides, read through The Body's collection of materials.